Skip to main content

Day: October 2, 2020

QCI’s Growing Number of Mukai Quantum Software Platform Trial Users Confirm Superior Performance and Ease-of-Use

LEESBURG, Va., Oct. 02, 2020 (GLOBE NEWSWIRE) — Quantum Computing Inc. (OTC:QUBT) (QCI), the technology leader in quantum-ready applications and tools, and only public pure-play in quantum computing, reports that the number of users on its performance-leading Mukai™ quantum software development and execution platform has increased significantly since the introduction of a new trial program launched at the end of June.“Dozens of new users have signed up for our Mukai trial, including major enterprises from the technology and finance sectors, U.S. Department of Energy national labs, large universities, and quantum computer (QC) providers,” stated John Dawson, QCI’s director of program management. Dawson, who oversees the trial program, previously led Cray Research’s worldwide IT organization and the software development team for its...

Continue reading

FTI Foodtech International Inc. to Market Rapid-Result Serological COVID-19 Antibody Test Kit

TORONTO, Oct. 02, 2020 (GLOBE NEWSWIRE) — (TSX Venture: FTI) — FTI Foodtech International Inc. (“FTI”) has obtained a letter of authorization from Rapid Virus Detect Ltd. – a medical device importer and distributor in British Columbia – for marketing, sales and after-sales services of their rapid-result, serological COVID-19 Antibody Test Kit, worldwide.This COVID-19 (SARS-Co-V-2) IgM/IgG Antibody Test Kit is manufactured by Wuhan EasyDiagnosis Biomedicine Co., Ltd of Wuhan, China. The kit, which provides qualitative detection of anti-SARS-CoV-2 IgM and IgG antibody in human serum, plasma and whole blood, is a nucleic acid extraction reagent test for use by health professionals. The test kit will detect the immunoglobulin IgM (the fast-acting antibody) and the immunoglobulin IgG (the long-lasting antibody)...

Continue reading

FTI Foodtech International Inc. commercialisera un kit de test sérologique, à résultat rapide, d’anticorps COVID-19

TORONTO, 02 oct. 2020 (GLOBE NEWSWIRE) — FTI Foodtech International Inc. (TSXV : FTI) (« FTI » ou la « Société ») a obtenu une lettre d’autorisation de Rapid Virus Detect Ltd., un importateur et distributeur de dispositifs médicaux en Colombie-Britannique, pour la vente, le marketing ainsi que le service après-vente de leur kit de test sérologique, à résultat rapide, d’anticorps COVID-19, et ce, dans le monde entier.Ce kit de test d’anticorps IgM/IgG COVID-19 (SARS-Co-V-2) est fabriqué par Wuhan EasyDiagnosis Biomedicine Co., Ltd basée à Wuhan, en Chine. Le kit qui fournit une détection qualitative des anticorps anti-SARS-CoV-2 IgM et IgG dans le sérum, le plasma et dans le sang total des humains, est un test réactif à l’extraction d’acide nucléique utilisé par les professionnels de la santé. Le kit de test détectera, dans les 15 minutes,...

Continue reading

Company with Expertise in Smoking Cessation Announces Patent, Creation of Lab

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) — NetworkNewsAudio – Kaival Brands Innovations Group Inc. (OTCQB: KAVL) announces the availability of a broadcast titled, “Desperate Need Fuels New Products, Programs in Smoking Cessation Space.”To hear the AudioPressRelease, please visit: The NetworkNewsAudio News PodcastTo view the full editorial, please visit: https://nnw.fm/eGyr0Approximately 1,300 people die every day as a result of smoking, and more than 16 million Americans are living with a disease caused by smoking. These alarming numbers aren’t going unnoticed, and companies with expertise in the space are seizing the opportunity to provide solutions designed to help smokers kick the habit.One of those companies, Kaival Brands Innovations Group Inc. (OTCQB: KAVL), has just acquired a patent covering the creation of all synthetic...

Continue reading

Constellation Brands Elects Nicholas Fink of Fortune Brands Home & Security, Inc. to Its Board of Directors

VICTOR, N.Y., Oct. 02, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today the election of Nicholas I. Fink, chief executive officer of Fortune Brands Home & Security, Inc., to serve as a member of its board of directors, effective as of the close of business on January 4, 2021. This election increases the size of Constellation’s board from 12 to 13 members.“We are excited to welcome Nick to our board of directors,” said Rob Sands, Constellation Brands’ Executive Chair of the Board of Directors. “Nick brings extensive beverage alcohol, international business, and legal experience, and has a proven track record of leveraging consumer insights to meet consumer needs in fast moving, highly regulated markets. Nick will serve as a tremendous asset for our...

Continue reading

Better Choice Closes $17.8M Insider-led Financing to Expand Its Rapidly Growing E-Commerce, Direct to Consumer and International Channels

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice” or “the Company”), an animal health and wellness company, today announced the closing of a $17.8M Series F financing. As part of this financing, Management and Board members funded approximately $11M.“We are all very excited about reaching this pivotal point for Better Choice’s capital structure,” said Michael Young, Chairman of the Board and a key investor in the Series F financing.“I have been an active investor in Better Choice for more than two years, having watched it grow into the multi-channel global player it is today. The positive secular trends in the pet sector have never been so strong, and I believe that Better Choice is extremely well positioned in E-Commerce, DTC and Asia to capitalize on the market...

Continue reading

WisdomTree Wins Best International Equity ETF Issuer ($1BN+) at the ETF Express US Awards

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) — WisdomTree Investments, Inc. (NASDAQ: WETF), an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager, is pleased to announce that it has been named Best International Equity ETF Issuer ($1BN+) by the ETF Express US Awards 2020, which recognizes excellence among ETF issuers and service providers across a wide range of categories.Jarrett Lilien, WisdomTree President and COO said, “Innovation is at the core of WisdomTree’s product development process. Our robust team is continually reevaluating the strength of our offerings and looking for new ways to innovate and provide competitive solutions in the market. We are able to do that effectively by listening to investors, possessing a deep understanding of market influences and considering the competitive...

Continue reading

PHOTO RELEASE — Ingalls Shipbuilding Successfully Completes Acceptance Trials for Stone (WMSL 758)

PASCAGOULA, Miss., Oct. 02, 2020 (GLOBE NEWSWIRE) — Huntington Ingalls Industries’ (NYSE: HII) Ingalls Shipbuilding division announced today the successful completion of acceptance sea trials for the U.S. Coast Guard’s newest national security cutter, Stone (WMSL 758). During seal trials, the ship spent two days in the Gulf of Mexico proving its systems.“I am very proud of the Ingalls team that conducted another outstanding acceptance trial on our ninth national security cutter Stone. This ship, like all of the national security cutters we have delivered, will be capable of undertaking the most challenging Coast Guard missions with great capability and endurance,” Ingalls Shipbuilding President Brian Cuccias said. “We are proud of our shipbuilders and the state-of-the-art design and construction of Stone, and we look forward to...

Continue reading

New Data Released from the Mayo Clinic Utilizing Daxor’s BVA-100® Test Highlights Value of Daxor’s Diagnostic at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new data from the Mayo Clinic showing that Daxor’s Blood Volume diagnostic test utilizing its BVA-100 device is clinically superior to the common proxy marker of weight loss to measure progress in heart failure (HF) treatment. This data was presented at the Heart Failure Society of America’s (HFSA) Virtual Annual Scientific Meeting 2020 currently in progress.The study, “Why Is Diuresis-related Weight Loss Not A Consistent Predictor Of Clinical Outcomes In Heart Failure? – Need To Account For Variability In Volume Status” by Dr. Wayne Miller at the Mayo Clinic in Rochester MN explored the outcomes of two metrics...

Continue reading

Cocrystal Pharma Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

BOTHELL, WA, Oct. 02, 2020 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (NASDAQ: COCP) The following is being released by Cocrystal Pharma, Inc. pursuant to an order of the United States District Court, District of New Jersey, regarding Agreement of Settlement.UNITED STATES DISTRICT COURTDISTRICT OF NEW JERSEYNOTICE OF PROPOSED SETTLEMENT OF DERIVATIVE ACTIONTO: ALL OWNERS OF COCRYSTAL PHARMA, INC. F/K/A BIOZONE PHARMACEUTICALS, INC. (“COCRYSTAL” OR THE “COMPANY”) COMMON STOCK (TICKER SYMBOL: COCP) AS OF AUGUST 20, 2020, WHO CONTINUE TO OWN SUCH SHARES THROUGH DECEMBER 16, 2020 (“CURRENT COCRYSTAL STOCKHOLDERS”).PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. THIS NOTICE RELATES TO A PROPOSED SETTLEMENT AND DISMISSAL OF STOCKHOLDER DERIVATIVE LITIGATION AND CONTAINS IMPORTANT INFORMATION REGARDING YOUR RIGHTS.IF THE COURT APPROVES...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.